Apitherapy for Prostate

Dr. Weeks’ Comment:  Prof. Berger, a co-learner with me, has graciously shared his collection of apitherapy for prostate health.    Wow – read on!  And then make an appointment with your local, friendly beekeeper.


Beehive extract shows potential as prostate cancer treatment

Proteomics reveals how ancient remedy slows prostate tumor cell proliferation

An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine.

Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives. Propolis has been used for centuries as a natural remedy for conditions ranging from sore throats and allergies to burns and cancer. But the compound has not gained acceptance in the clinic due to scientific questions about its effect on cells.

In a paper published in Cancer Prevention Research, researchers combined traditional cancer research methods with cutting-edge proteomics to find that CAPE arrests early-stage prostate cancer by shutting down the tumor cells’ system for detecting sources of nutrition.

“If you feed CAPE to mice daily, their tumors will stop growing. After several weeks, if you stop the treatment, the tumors will begin to grow again at their original pace,” said Richard B. Jones, PhD, assistant professor in the Ben May Department for Cancer Research and Institute for Genomics and Systems Biology and senior author of the study. “So it doesn’t kill the cancer, but it basically will indefinitely stop prostate cancer proliferation.”

Natural remedies isolated from plant and animal products are often marketed as cure-alls for a variety of maladies, usually based on vague antioxidant and anti-inflammatory claims. While substances such as ginseng or green tea have been occasionally tested in laboratories for their medicinal properties, scientific evidence is commonly lacking on the full biological effects of these over-the-counter compounds.

“It’s only recently that people have examined the mechanism by which some of these herbal remedies work,” Jones said. “Our knowledge about what these things are actually doing is a bit of a disconnected hodge-podge of tests and labs and conditions. In the end, you’re left with a broad, disconnected story about what exactly these things are doing and whether or not they would be useful for treating disease.”

To study the purported anti-cancer properties of CAPE, first author Chih-Pin Chuu (now at the National Health Research Institutes in Taiwan) tested the compound on a series of cancer cell lines. Even at the low concentrations expected after oral administration, CAPE successfully slowed the proliferation of cultured cells isolated from human prostate tumors.

CAPE was also effective at slowing the growth of human prostate tumors grafted into mice. Six weeks of treatment with the compound decreased tumor volume growth rate by half, but when CAPE treatment was stopped, tumor growth resumed its prior rate. The results suggested that CAPE stopped cell division rather than killing cancerous cells.

To determine the cellular changes that mediated this effect, the researchers then used an innovative proteomics technique invented by Jones and colleagues called the “micro-western array.” Western blots are a common laboratory tool used to measure the changes in protein levels and activity under different conditions. But whereas only one or a few proteins at a time can be monitored with Western blots, micro-western arrays allow researchers to survey hundreds of proteins at once from many samples.

Chuu, Jones and their colleagues ran micro-western arrays to assess the impact of CAPE treatment on the proteins of cellular pathways involved in cell growth – experiments that would have been prohibitively expensive without the new technique.

“What this allowed us to do is screen about a hundred different proteins across a broad spectrum of signaling pathways that are associated with all sorts of different outcomes. You can pick up all the pathways that are affected and get a global landscape view, and that’s never been possible before,” Jones said. “It would have taken hundreds of Westerns, hundreds of technicians, and a very large amount of money for antibodies.”

The micro-western array results allowed researchers to quickly build a new model of CAPE’s cellular effects, significantly expanding on previous work that studied the compound’s mechanisms. Treatment with CAPE at the concentrations that arrested cancer cell growth suppressed the activity of proteins in the p70S6 kinase and Akt pathways, which are important sensors of sufficient nutrition that can trigger cell proliferation.

“It appears that CAPE basically stops the ability of prostate cancer cells to sense that there’s nutrition available,” Jones said. “They stop all of the molecular signatures that would suggest that nutrition exists, and the cells no longer have that proliferative response to nutrition.”

The ability of CAPE to freeze cancer cell proliferation could make it a promising co-treatment alongside chemotherapies intended to kill tumor cells. Jones cautioned that clinical trials would be necessary before CAPE could be proven effective and safe for this purpose in humans. But the CAPE experiments offer a precedent to unlock the biological mechanisms of other natural remedies as well, perhaps allowing these compounds to cross over to the clinic.

“A typical problem in bringing some of these herbal remedies into the clinic is that nobody knows how they act, nobody knows the mechanism, and therefore researchers are typically very hesitant to add them to any pharmaceutical treatment strategy,” Jones said. “Now we’ll actually be able to systematically demonstrate the parts of cell physiology that are affected by these compounds.”


The paper, “Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks,” will be published online May 4 by Cancer Prevention Research. In addition to Chuu and Jones, authors include Mark F. Ciaccio, John M. Kokontis, Ronald J. Hause, Jr., Richard A. Hiipakka and Shutsung Liao of the University of Chicago; and Hui-Ping Lin of the National Health Research Institutes in Taiwan.

Research was supported by grants from the Cancer Research Foundation, American Cancer Society, National Institutes of Health, U.S. Department of Health, and National Science Council.

For more news from the University of Chicago Medicine, follow us on Twitter at @UChicagoMed, or visit our Facebook page at facebook.com/UChicagoMed, our research blog at sciencelife.uchospitals.edu, or our newsroom at uchospitals.edu/news.

Also positive results re breast cancer:




The phenolic content of different types of honey can vary greatly. The phenolic compounds contribute significantly to the antioxidant capacity of honey, but are not solely responsible for it. The darkest honeys, such as buckwheat honey, are a better source of antioxidants than lighter-colored honeys.



Asked quantity of CAPE in various products;

toothpaste  — also avail at Amazon





CAPE – (Caffeic acid phenethyl ester,) is part of honey/propolis,
that has been shown to stop all tumor growth, as long as it is taken.  Note, this does not seem to reverse/remove cancer, but it will stop tumor growth, which presumably give more time for other, preferably natural substances to work.

The propolis/honey from New Zealand seems to have many times more CAPE than other souces.








Osamu Mizukami,MD,PhD,DrPH
Health Promotion Clinic, Tokyo

I have treated over 500 patients with advanced cancer using propolis.

I have been using ethanol”extracted, 30% (w/v) of Brazilian propolis derived from the Baccharis dracunculifolia plant.

Although my usual recommended dose for propolis is 10 ml (3g) of propolis a day, I have been using 30 ml (9g) or more


CAPE and aggressive breast cancer:



Note:  I just rec’d Bio 30 Manuka Propolis, which seems to be highest content of CAPE.

We’re trying to get pure CAPE, but apparently the manufacturer want to make sure it is not for human use — apparently because it might help some people?


Cancer Prev Res (Phila). 2012 May;5(5):788-97.

Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.

Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ Jr, Hiipakka RA, Liao S, Jones RB.


The Ben May Department for Cancer Research, The University of Chicago, IL 60637, USA.


Caffeic acid phenethyl ester (CAPE) is a bioactive component derived from honeybee hive propolis. CAPE has been shown to have antimitogenic, anticarcinogenic, and other beneficial medicinal properties. Many of its effects have been shown to be mediated through its inhibition of NF-κB signaling pathways. We took a systematic approach to uncover the effects of CAPE from hours to days on the signaling networks in human prostate cancer cells. We observed that CAPE dosage dependently suppressed the proliferation of LNCaP, DU-145, and PC-3 human prostate cancer cells. Administration of CAPE by gavage significantly inhibited the tumor growth of LNCaP xenografts in nude mice. Using LNCaP cells as a model system, we examined the effect of CAPE on gene expression, protein signaling, and transcriptional regulatory networks using micro-Western arrays and PCR arrays. We built a model of the impact of CAPE on cell signaling which suggested that it acted through inhibition of Akt-related protein signaling networks. Overexpression of Akt1 or c-Myc, a downstream target of Akt signaling, significantly blocked the antiproliferative effects of CAPE. In summary, our results suggest that CAPE administration may be useful as an adjuvant therapy for prostate and potentially other types of cancers that are driven by the p70S6K and Akt signaling networks.



Leading prostate cancer expert, Dr. David Samadi, explains how this glue-like substance used by bees to repair hives is believed to work. “In this study, CAPE appeared to block the prostate cancer tumor cells from finding their next meal. When the cells can’t identify sustenance, they stop dividing. If the cells don’t divide, the tumor doesn’t grow.”

“First, this research has not yet been conducted with men. Second, CAPE doesn’t kill prostate cancer cells and it only arrests their growth for the duration of the treatment. Still, this initial success could help us learn more about early stage prostate cancer and the disease’s development.”

human prostate cancer cells



At the end of the day, this “landscape view” allowed the scientists to pinpoint exactly what happens at the protein level when chemically-complex CAPE is used to treat prostate cancer. In technical terms, they found that CAPE suppresses protein activity in the p70S6 kinase and Akt pathways.

What’s interesting is that both pathways are nutrition sensors. When activated, they give cancer cells the green light to proliferate. When deactivated, they stop cell growth in its tracks.

Times of India, prostate info/studies:

Leave a Comment

Your email address will not be published. Required fields are marked *